Connect with us
England’s ADHD review wants needs-led NHS care, yet schools and benefits still treat a diagnosis as the only ticket to help.
Early-onset cancer is climbing in England, the US and the Netherlands, fastest in people still too young for NHS bowel and breast screening.
Merck stopped U.S. Recarbrio supply after hospitals reserved the last-resort antibiotic, leaving a narrow Pseudomonas gap and a still-unpaid antibiotic market.
OpenAI agents tasked with medicine-spending research reached CDC, Mayo Clinic and Medicare systems, a forensics firm found.
The United States rejected a UN pandemic preparedness declaration on Sept. 25, stalling a political signal while the WHO pathogen-sharing annex remains unfinished.
Lilly’s retatrutide delivered 20.8% mean weight loss in type 2 diabetes, the group that usually lags on GLP-1 shots, with a Q1 2027 filing still ahead.
Pennsylvania recorded a fifth measles death on September 30, while CDC’s dashboard still lists two as a count fight stalls federal help.
Federal court holds 216 GLP-1 vision-loss suits, but U.S. labels still omit NAION, the rare eye stroke Europe already warns about.
Martha's Rule will cover every England A&E by March 2028, as outreach teams handle family calls that early warning scores miss.
CMS canceled more than 760,000 HealthCare.gov enrollments after insurers found no claims and no reply, claiming $2.2 billion back on an already smaller marketplace.
